Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	679	296	253	259	453	591
Market Cap Growth	131.94%	17.18%	-2.48%	-42.79%	-23.38%	64.89%
Enterprise Value	629	335	295	269	403	560
Last Close Price	36.58	16.82	14.50	15.00	26.50	35.00
PE Ratio	6.96	16.95	-	-	-	-
Forward PE	15.34	17.39	-	-	-	-
PS Ratio	2.42	1.65	2.18	2.24	3.27	5.45
PB Ratio	8.01	90.11	-8.83	-19.04	14.92	17.38
P/TBV Ratio	12.07	-	-	-	14.92	17.38
P/FCF Ratio	10.28	9.43	-	-	86.30	-
P/OCF Ratio	10.27	9.41	-	-	77.10	-
EV/Sales Ratio	2.35	1.87	2.55	2.33	2.90	5.15
EV/EBITDA Ratio	5.88	12.69	-	-	-	-
EV/EBIT Ratio	6.01	13.86	-	-	-	-
EV/FCF Ratio	9.56	10.67	-	-	76.67	-
Debt / Equity Ratio	0.75	30.40	-3.64	-6.44	3.01	1.15
Debt / EBITDA Ratio	0.57	3.68	-	-	-	-
Debt / FCF Ratio	0.93	3.18	-	-	17.38	-
Asset Turnover	1.60	1.27	0.92	0.77	1.00	0.84
Inventory Turnover	3.54	5.49	2.76	5.17	10.82	12.21
Quick Ratio	1.71	1.88	1.64	1.51	2.21	1.80
Current Ratio	2.02	2.13	1.86	1.78	2.43	2.18
Return on Equity (ROE)	376.09%	-	-	-699.04%	-55.63%	-67.72%
Return on Assets (ROA)	39.01%	10.75%	-10.68%	-24.34%	-8.77%	-14.04%
Return on Capital (ROIC)	61.27%	16.92%	-17.95%	-37.50%	-12.50%	-22.19%
Return on Capital Employed (ROCE)	87.10%	24.00%	-	-	-	-
Earnings Yield	14.47%	5.90%	-9.92%	-22.59%	-3.95%	-5.03%
FCF Yield	9.73%	10.61%	-2.27%	-28.62%	1.16%	-9.04%
Buyback Yield / Dilution	-2.96%	-1.64%	-2.07%	0.00%	-1.03%	-0.81%

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q